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Higher  titre processes  can  pose  facility  ﬁt challenges  in  legacy  biopharmaceutical  puriﬁcation  suites  with
capacities originally  matched  to lower  titre  processes.  Bottlenecks  caused  by mismatches  in equipment
sizes,  combined  with  process  ﬂuctuations  upon  scale-up,  can  result  in discarding  expensive  product.  This
paper  describes  a data  mining  decisional  tool  for  rapid  prediction  of facility  ﬁt issues  and  debottlenecking
of  biomanufacturing  facilities  exposed  to  batch-to-batch  variability  and  higher  titres.  The  predictive  tool
comprised  advanced  multivariate  analysis  techniques  to interrogate  Monte  Carlo  stochastic  simulation
datasets  that  mimicked  batch  ﬂuctuations  in  cell  culture  titres,  step  yields  and  chromatography  eluate
volumes.  A  decision  tree  classiﬁcation  method,  CART  (classiﬁcation  and  regression  tree)  was introduced
to  explore  the  impact  of these  process  ﬂuctuations  on  product  mass  loss  and  reveal  the  root  causes
of  bottlenecks.  The  resulting  pictorial  decision  tree  determined  a series  of  if-then  rules  for  the  criticalata mining combinations  of  factors  that  lead to  different  mass  loss  levels.  Three  different  debottlenecking  strategies
were  investigated  involving  changes  to equipment  sizes,  using  higher  capacity  chromatography  resins
and elution  buffer  optimisation.  The  analysis  compared  the  impact  of  each  strategy  on  mass  output,  direct
cost of  goods  per  gram  and  processing  time,  as well  as consideration  of extra  capital  investment  and  space
requirements.
ublis© 2014  The  Authors.  P
. Introduction
In recent years, cell culture titres of monoclonal antibodies
mAbs) have increased dramatically as a result of improvements
o cell lines, media composition, and feeding strategies (Birch and
acher, 2006; Li et al., 2010). Furthermore, it is common for titres
o increase by 50% or more as a product progresses from early to
ate process development (Kelley et al., 2009). Higher titre pro-
esses can pose facility ﬁt challenges for downstream processing
DSP), particularly during tech transfer to legacy biopharmaceuti-
al manufacturing facilities that were constructed with multiple
arge-volume bioreactors (>10,000 L) and DSP capacities matched
o lower titre processes. Legacy facilities can struggle to cope with
he resulting higher protein loads onto DSP due to bottlenecks
∗ Corresponding author at: University College London, Biochemical Engineering,
orrington Place, London WC1E 7JE, UK. Tel.: +44 20 7679 4415.
∗∗ Corresponding author at: Imperial College London, Department of Chemical
ngineering, London SW7  2AZ, UK Tel.: +44 (0)20 7594 6622.
E-mail addresses: s.farid@ucl.ac.uk (S.S. Farid), n.thornhill@imperial.ac.uk
N.F. Thornhill).
ttp://dx.doi.org/10.1016/j.jbiotec.2014.03.004
168-1656/© 2014 The Authors. Published by Elsevier B.V. This is an open access article uhed  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/3.0/).
reached in DSP unit operations (e.g. chromatography columns) or
tank storage capacities (Aldington and Bonnerjea, 2007; Chang,
2011; Farid, 2008; Kamarck, 2006; Kelley, 2009; Stonier et al.,
2012). Thus systematic and rigorous tools for facility ﬁt analysis
and debottlenecking are critical to gaining greater understanding
of the root causes of suboptimal facility ﬁt and identifying the most
promising debottlenecking strategies.
Facility ﬁt analysis and DSP debottlenecking efforts are com-
plicated by the inherent batch-to-batch variability present in
bioprocess unit operations (Farid, 2008; Stonier et al., 2013). Facil-
ity ﬁt assessments that are based on single point expected values
for key process parameters, and hence do not account for process
ﬂuctuations, may  not identify the correct bottleneck. Certain com-
binations of worst case values can lead to volumes that exceed
equipment capacities and result in having to discard expensive
product. The likelihood and consequences of such scenarios would
not be captured by facility ﬁt assessments based solely on expected
values. Furthermore, large scale facilities often have ﬁxed stain-
less steel equipment and piping networks. This makes it harder to
adopt debottlenecking strategies involving equipment changes in
response to ﬁt issues arising from process variability and higher
titres.
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Table 1
Facility speciﬁcation for the chromatography and ﬁltration downstream processing
steps.
Parameter Step
Chromatography Protein A AEX CEX
Column diameter (m)  1 1 1
Bed  height (m)  0.20 0.25 0.15
Bed  volume (L) 157 196 118
Load capacity (g/L) 25 50 15
Linear velocity (cm/h) 450 450 140
Expected number of cycles 9 3 15
Expected pool volume (CV/cycle) 2 3 2.5
Pool  tank volume (L) 5000 5000 5000
Expected step yield (%) 88 88 88
Filtration Post Protein
A UF/DF
Post AEX UF Final UF/DF VRF
Retentate tank volume
(L)
5000 5000 5000 5000
Expected average ﬂux
rate (L/m2 h)
100/55 110/60 140/80 N/A
Target concentration
(g/L)
25 25 38
Diaﬁltration volumes
(CV)
3 0 10 0
Expected step yield (%) 95 95 95 99
Note: Pool volume refers to the volume of the product stream. In Protein A and CEX8 Y. Yang et al. / Journal of B
Effective facility ﬁt assessments can beneﬁt from advanced data
ining of datasets generated from bioprocess models that can
apture the dynamics of bioprocesses as well as the impact of
esource constraints and process variability. Commercial biopro-
ess modelling packages (e.g. Superpro Designer (Intelligen, Inc.,
cotch Plains, NJ) tend to be useful for equipment sizing and cost-
ng but are not typically designed to capture the consequences
f resource delays (e.g. due to buffer storage tank availability) or
ncertainties (e.g. titre). In this work, a discrete-event data-driven
imulation platform developed by the Advanced Centre for Bio-
hemical Engineering at UCL (Stonier et al., 2012, 2013) was  used
o model the performance of bioprocesses exposed to uncertain-
ies and facility constraints. The model captures the mass balances,
quipment sizing, dynamic resource allocation and process eco-
omics of puriﬁcation sequences. Monte Carlo simulation methods
ave been used in this work to mimic  a batch history record by
ccounting for key process ﬂuctuations and generating the possible
utcomes and their likelihood. These simulations enable predic-
ions of the impact of process ﬂuctuations on the possibility of
roduct loss. Monte Carlo simulation has been used increasingly
n various bioprocessing examples to capture the impact of techni-
al, clinical or commercial uncertainties on unit operation models
Sin et al., 2009), whole bioprocess costs (Farid et al., 2005; Pollock
t al., 2013) and on portfolio management and capacity planning
ecisions (George and Farid, 2008).
Data mining has been used in the biotech sector to identify
rends in large datasets from historical batch records, often applied
o fermentation data (Charaniya et al., 2010; Mercier et al., 2013;
ommel and Schuppert, 2004). Principal component analysis (PCA)
s a common multivariate analysis method that uses an ortho-
onal transformation to convert a set of variables into a set of
inearly uncorrelated variables. It has been applied in manufactur-
ng process analysis to reveal the internal structure and pattern
f historical data (Edwards-Parton et al., 2008; Pate et al., 1999;
hornhill et al., 2006) but cannot generate the potential rules hid-
en behind the data. Decision tree classiﬁcation is an effective data
ining method that has been applied in fermentation parameter
dentiﬁcation (Buck et al., 2002; Ma  et al., 2004) and fermentation
rocess optimization (Coleman et al., 2003; Lam and Malik, 2001).
n this work, the classiﬁcation and regression tree (CART) was
ntroduced to analyse the large complex downstream manufac-
uring bioprocess datasets generated by Monte Carlo simulations
nd to ﬁnd the hidden root causes of bottlenecks in existing facil-
ties exposed to batch-to-batch variability and higher titres. The
ata mining outputs can be used to support better process under-
tanding through rigorous root cause analysis and continuous risk
anagement and hence contribute to effective implementation of
uality by design (QbD) principles throughout the lifecycle of a
roduct.
This paper is organized as follows. First, downstream bioprocess
acilities used in the case study are described. Second, the methods
pplied in the case study including stochastic discrete-event simu-
ation, correlation coefﬁcients analysis and CART decision trees are
rieﬂy introduced. In Section 4, the Monte Carlo simulation datasets
re analysed to identify mismatches in pool volumes resulting in
roduct losses. The key process ﬂuctuations leading to mass loss
nd threshold values for those process ﬂuctuations are derived
sing CART decision trees. This work demonstrated that the deci-
ion tree classiﬁcation method can be applied to explore not only
he impact of process ﬂuctuations on product mass loss but also the
ritical combinations of parameter values that lead to mass loss.
urthermore, the pictorial CART tree result with its series of if-then
ules of the critical combinations of factors that lead to different
ass loss levels can be used to identify debottlenecking solutions
orth pursuing. Finally, three different debottlenecking solutions
re compared in relation to their impact on three key metrics: masssteps operated in bind-and-elute mode this refers to the eluate volume collected. In
AEX operated in ﬂow-through mode this refers to the load and post wash volumes
collected.
output, direct cost of goods per gram (COG/g) and processing time.
The solutions explored spanned changes to equipment sizing, using
more efﬁcient puriﬁcation resins and reducing the eluate volume
ﬂuctuations expected through buffer optimisation.
2. Problem domain
An existing standard monoclonal antibody (mAb) manufac-
turing process was  considered in this work, as shown in Fig. 1.
The volume of bioreactor broth generated during each batch was
10,000 L. Biomass and other debris were removed using centrifuga-
tion and depth ﬁltration with step recovery yields of 95%. The mAb
downstream processing sequence was  deﬁned as: Protein A afﬁnity
chromatography capture step, low pH virus inactivation, ultraﬁltra-
tion/diaﬁltration (UF/DF), anion exchange chromatography (AEX),
ultraﬁltration (UF), cation exchange chromatography (CEX), virus
reduction ﬁltration (VRF) and a ﬁnal UF/DF.
The downstream process was originally built to handle titres
up to 2 g/L but it now needed to cope with average titres of 4 g/L
and hence a harvest kg/batch value of 40 kg rather than 20 kg. The
impact of the higher titre feed on the number of cycles required for
each DSP step and hence the expected pool volumes from each step
were calculated and used to allocate larger product collection tanks
where appropriate. The speciﬁcation of the downstream process
equipment sizes and process parameters (e.g. resin binding capaci-
ties) is presented in Table 1. This facility conﬁguration, modiﬁed to
cope with 4 g/L titre feeds, was  identiﬁed as the base case facility.
The aim was to investigate the impact of batch-to-batch variability
on its performance and predict facility ﬁt issues.
Facility ﬁt assessments are carried out often with information
from a limited number of batches at scale, particularly for new
processes or new drug candidates. In the absence of a signiﬁcant
number of batch history records such assessments are typically
based on expected or worst case values which do not capture the
full range of possible outcomes or their likelihood of occurrence.
Hence in this paper stochastic simulation datasets were generated
as a mimic  of batch record data and then analysed using data mining
techniques. The simulation datasets capture typical batch-to-batch
variability expected at large scale which can be useful to companies
Y. Yang et al. / Journal of Biotechnology 179 (2014) 17–25 19
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VFig. 1. A standard monoclonal antibody (mAb) manufacturing process. VI = vi
or predicting facility ﬁt issues and bottlenecks when new pro-
esses are introduced into an existing facility. This work integrates
tochastic simulation with data mining to identify the hidden rea-
ons behind bottlenecks in the facility that result in product being
iscarded and then uses these insights to propose and evaluate
ossible debottlenecking solutions.
. Methodology
.1. Stochastic discrete-event simulation
A database-driven discrete-event simulation tool (Stonier et al.,
012) developed in ExtendSim 8 (Imagine That! Inc, San Jose, USA)
as used to simulate the manufacturing process under uncer-
ainty using Monte Carlo simulations. In this work, the simulation
akes input variables such as facility data (e.g. availability of differ-
nt equipment sizes), process data (e.g. process sequence, process
arameters) and economic data (e.g. chromatography resin and
uffer costs). Examples of key input variables are shown in Table 1.
he output variables are key scheduling parameters (e.g. batch
urations, delays), technical performance metrics (e.g. mass output
nd product loss) and ﬁnancial metrics (e.g. COG/g).
In order to mimic  batch-to-batch variability caused by ﬂuctu-
tions in real manufacturing conditions, representative triangular
istributions indicated in Table 2 were assigned to four key param-
ter types: product titre, step yields for the puriﬁcation steps,
hromatography eluate volumes and ﬁlter ﬂux rates. Triangular dis-
ributions were used since typical minimum, maximum and most
ikely values for each of the parameters could be derived through
iscussions with industrial experts in the user consortium of the
PSRC Centre for Innovative Manufacturing in Emergent Macro-
olecular Therapies as well as literature sources (Amanullah et al.,
010; Abu-Absi et al., 2010; Legmann et al., 2009). For example,
 ±10% variation in product titres was captured which affects the
ass load of product onto the chromatography steps and hence the
umber of cycles in each chromatography step. In this work, the
hromatography eluate volume refers to the pool volume per cycle
hich is the number of column volumes collected per chromatog-
aphy cycle in bind-and-elute mode or the number of load and
ost wash column volumes collected per chromatography cycle
n ﬂow-through mode. In this case study, a value of ±50% varia-
ion in eluate volumes was considered to reﬂect the challenges in
redicting the position and shape of the product peak on the UV
able 2
ariable distribution ranges.
Variable Min  (%) Most Max  (%)
Product titre −10 Base case 10
Eluate volumes −50 Base case 50
Filter ﬂux rates −10 Base case 10
Step  yield
Chromatography steps 83 88% 93
Virus inactivation 98 99% 100
Ultraﬁltration/diaﬁltration 90 95% 99
Virus retention ﬁltration 90 95% 99ctivation, UF/DF = ultraﬁltration/diaﬁltration, VRF = virus retention ﬁltration.
trace and hence the collection criteria for the eluate upon trans-
fer of a process to a new facility. This is particularly the case when
signiﬁcant leading or tailing on the elution peaks is observed with
steps that are highly sensitive to pH and conductivity of the elution
buffer (Stonier et al., 2013). Whilst sensible ranges in process vari-
ability were sought for each of the parameters, the primary aim of
the paper was to demonstrate the application of the proposed data
mining methodology to perform more rigorous and predictive facil-
ity ﬁt assessments. Hence, the actual inputs and answers should not
be seen as deﬁnitive but an illustration of how to approach such an
assessment.
In Monte Carlo simulation methods, convergence diagnostics
is an important topic because lack of convergence would affect
the reliability of the simulation result (Cassettari et al., 2012). In
this work, convergence was  tested on all dynamic variables. Four
hundred iterations were sufﬁcient to reach convergence and hence
provided reliable probability distributions of possible outcomes for
analysis. The Monte Carlo simulation was set up to run for 400 itera-
tions to generate the stochastic dataset for data analysis. The values
of the uncertain input parameters (product titre, step yields, chro-
matography eluate volumes and ﬁlter ﬂux rates) vary under the
triangular distributions described in Table 2 from run to run. All
input variables as well as the key outputs such as mass loss were
recorded for each iteration. After the simulation experiments, the
results were used to generate frequency distribution plots of mass
loss and pool volumes at each step such as those presented later
in Fig. 2 and to enable the root causes of unwanted events to be
investigated using data mining techniques.
3.2. Correlation coefﬁcients analysis
Correlation coefﬁcients usually known as Pearson’s prod-
uct moment correlation coefﬁcients provide a measure of the
strength of the linear relationship between two  variables (Rodgers
and Nicewander, 1988). Correlation coefﬁcients between two N-
dimensional vectors x and y is deﬁned by
xy =
∑N
k=1 (xk − x¯) (yk − y¯)√∑N
k=1 (xk − x¯)
2
√∑N
k=1(yk − y¯)
2
(1)
where x¯ and y¯ are deﬁned as the mean of x and y, respectively.
Correlation coefﬁcients only measure the linear relationship
between two variables. So when more than one input factor is
under consideration, partial correlation coefﬁcients can be used to
characterize the strength of the linear relationship between two
variables when all linear effects of other variables are removed.
X1,Y |Z is the partial correlation coefﬁcient of X1 (e.g. titre) and Y
(unexpected mass loss caused by process ﬂuctuations in this work)
holding Z = X2,. . .,Xk (e.g. step yields, eluate volumes and other pro-
cess parameters except titre):X1,Y |Z =
X1,Y − X1,Z × Y,Z√(
1 − 2X1,Z
)(
1 − 2Y,Z
) (2)
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Fig. 2. Distribution of mass loss and pool volumes for each process step. Mass loss can occur due to step yield losses as well as discarding product due to volume mismatches.
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In this work, partial correlation coefﬁcients have been used to
easure the parameter importance.
.3. Decision tree classiﬁcation
Decision tree algorithms are well-established machine learning
echniques that have been used for a wide range of applications,
specially for classiﬁcation problems (Grajski et al., 1986; Quinlan,
996). Decision trees were chosen for this case study given their
bility to convert large complex datasets into easy-to-understand
nd yet information-rich graphical displays. More speciﬁcally, the
esulting pictorial tree representation was considered a useful tool
or rapid elucidation of the critical combinations of parameter val-
es that lead to unacceptable product loss which could then be
onverted into a set of rules. Further advantages of using decision
ree algorithms include minimal requirements for data preparation
nd robust performance on large datasets.
CART (classiﬁcation and regression tree) is a nonparametric pro-
edure that uses a stepwise method to establish splitting rules
Breiman et al., 1984; Grajski et al., 1986). CART divides the data into
omogenous subsets using binary recursive partitions. The most
iscriminative variable is ﬁrst selected as the root node to partition
he data set into branch nodes. The root nodes and branch nodes
n this study represent critical process parameters driving product
oss. The partitioning is repeated until the nodes are homogenous
nough to be terminal nodes which are called leaves. The termi-
al nodes represent critical ranges for the output metric of interest
e.g. unexpected mass loss in this case study). So in a tree structure,
eaves represent class labels (e.g. <5% unexpected mass loss) and
ranches represent conjunctions of features (e.g. critical values for
itre and eluate volumes) that lead to those class labels.
.3.1. Gini impurity index for splitting
There are different splitting criteria for CART such as Gini impu-
ity index (Breiman et al., 1984; Sadras and Bongiovanni, 2004) and
woing (Piccarreta, 2008). The Gini index was used in this study.
ini impurity is a measure of how often a randomly chosen ele-
ent from the set would be incorrectly labelled if it were randomly
abelled according to the distribution of class labels in the subset.ch step processing. The dotted line indicates the anticipated mean loss due to step
re titre (4 g/L ± 10%), step yields, eluate volumes, and ﬁltration ﬂux rates (Table 2).
Gini impurity can be computed by summing the probability of each
item being chosen times the probability of a mistake in categoriz-
ing that item. It reaches its minimum (zero) when all cases in the
node fall into a single category or class label.
To compute Gini impurity for a set of items f, Eq. (3) is used
where the class label i takes on values in {1, 2,.  . .,m},  and fi is the
fraction of items labelled as category i in the set:
IG(f ) =
m∑
i=1
fi(1 − fi) =
m∑
i=1
fi −
m∑
i=1
f 2i = 1 −
m∑
i=1
f 2i (3)
3.3.2. Resubstitution estimation
Resubstitution estimate is the proportion of cases that are mis-
classiﬁed by the classiﬁer constructed from the entire learning set.
For a learning set consisting of (xi, ωi), i = 1, 2,. . .,N, where d(x) is the
classiﬁer, the resubstitution estimate is computed in the following
manner:
R(d) = 1
N
N∑
i=1
I{d(xi) /=  ωi} (4)
where I(•) is the indicator of event {•}; I{d(xi) /=  ωi} = 1, if the event
d(xi) /= ωi is true while I{d(xi) /=  ωi} = 0 if the event is false. In this
case study, xi is the ith case of learning set and its class label, ωi, is
0% unexpected mass loss, for example. The classiﬁer d is the CART
tree model built in Fig. 4 or 5 d(x1) is the predicted class label for
x1 using classiﬁer d. If the predicted class label d(x1) is 0–5% unex-
pected mass loss which is not the same as the class label ω1, then
I{d(xi) /= ωi} = 1, so the ith case is a misclassiﬁed case by the CART tree
classiﬁer.
3.3.3. k-Fold cross-validation
k-Fold cross-validation is a widely used technique for assessing
the robustness of a model. In k-fold cross-validation, the original
sample is randomly partitioned into k equal size subsamples. Of
the k subsamples, a single subsample is retained as the validation
data for testing the model, and the remaining k − 1 subsamples are
used as training data. The cross-validation process is then repeated
k times (the folds), with each of the k subsamples used exactly once
Y. Yang et al. / Journal of Biotechnology 179 (2014) 17–25 21
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hile negative correlation coefﬁcients represent negative linear relationships. The
etween process variables and unexpected product mass loss.
s the validation data. The k results from the folds can be averaged
o produce a single estimation. The advantage of this method over
epeated random sub-sampling is that all observations are used
or both training and validation, and each observation is used for
alidation exactly once. In this work, CART tool in Matlab Statis-
ics Toolbox was used and 10-fold cross-validation (Efron, 1983;
oreno-Torres et al., 2012) was applied for estimating the predic-
ion error.
. Results
.1. Bottleneck Identiﬁcation
The mass output of the facility (kg/batch) is one of the key
erformance metrics. The stochastic tool was used to predict the
requency distribution of mass output and the likelihood of mass
oss using Monte Carlo simulation, given the expected ﬂuctuations
n key performance indicators and puriﬁcation operating param-
ters indicated in Table 2. Fig. 7(a) shows the predicted batch
ass output for the processes running in the base case facility.
ased on deterministic values (product titre = 4 g/L, overall process
ield = 53%, fermenter scale = 10,000 L), the expected mass output
f the base case process should be 21 kg/batch. The values predicted
y the simulation fall well short of this value. A very small pro-
ortion of batches meet the expected output. This is suggestive of
acility ﬁt issues and prompts further investigation.
In order to identify the location of the equipment limitations
ausing the facility ﬁt issues, the product mass output and product
olume output of each process step have been examined. Fig. 2
hows the distribution of the product mass loss and pool volumes
t each step. The product mass loss at each step is deﬁned as the
ifference of product mass before and after each processing step.
sually, the product mass loss will be caused by step yield and
hould follow the step yield distribution described in Table 2. The
tep mass loss distribution plot in Fig. 2 identiﬁes abnormal mass
oss distributions in the AEX and CEX steps which mean unexpected
ass loss.
Furthermore, the step pool volume distribution plot in Fig. 2
eveals the bottleneck location. The vertical histogram plotted
longside each column of data points shows a spike in the distri-
utions at 5000 L for the AEX, CEX and VRF pool tanks. This is due
o the fact that the largest volume that can be stored in these tanks
as 5000 L. Surplus volume was diverted to waste and the product
as lost impacting throughput on a large number of batches. This
acility ﬁt issue was caused by the process ﬂuctuations and hence
s unexpected and hard to predict at the early process design stage.
n the following sections, the term unexpected mass loss means thet mass loss. Positive correlation coefﬁcients represent positive linear relationships
lute correlation coefﬁcient values can indicate the strength of linear dependence
mass loss caused by the process ﬂuctuations only excluding the loss
caused by step yields.
4.2. Partial correlation coefﬁcients analysis for variable
importance
Partial correlation coefﬁcients analysis was used to ﬁnd out
which of the uncertain input parameters (product titre, step yields,
chromatography eluate volumes and ﬁlter ﬂux rates) were more
important in determining the uncertainty in the key output of inter-
est, the overall unexpected product mass loss. Fig. 3 shows the
correlation coefﬁcients between the 18 input factors and overall
unexpected product mass loss. A positive correlation coefﬁcient
value means a positive relationship with the overall unexpected
product mass loss while a negative value means a negative relation-
ship. Fig. 3 shows that, at 0.6, the CEX eluate volume has the highest
positive correlation coefﬁcient followed by the AEX eluate volume
and titre. These three input parameters have the strongest inﬂuence
on the unexpected process mass loss. This reinforces observations
in Fig. 2 that the unexpected mass loss happened due to tank
volume limitations in CEX and AEX where the eluate volumes
were collected prior to further concentration. Although partial cor-
relation coefﬁcients can identify the most important drivers of
unexpected mass loss, they cannot offer detailed information about
how the most important variables impact the unexpected prod-
uct mass loss. In order to obtain an understanding of the critical
parameter values that combine to result in unexpected mass loss,
a decision tree analysis was performed to explore the base case
simulation data.
4.3. Decision tree analysis for debottlenecking
The Monte Carlo simulation dataset generated by the discrete-
event simulation tool has 400 data records. Each data record
represents one manufacturing batch. Before using the Monte Carlo
simulation dataset as a training dataset for the decision tree anal-
ysis, each data record was allocated a class label (as described in
Section 3.3.1) since decision tree classiﬁcation is a supervised learn-
ing method (Grajski et al., 1986). The expected mass load from the
10,000 L mAb  bioreactor was 40 kg. Unexpected mass loss per batch
exceeding 5% (2 kg) of the expected mass load was considered a
heavy unexpected mass loss. According to the quantity of product
loss, each data record in the Monte Carlo simulation dataset was
classiﬁed into one of three groups: 0% unexpected mass loss, 0–5%
unexpected mass loss and ≥5% unexpected mass loss. The summary
of the training dataset is shown in Table 3.
According to the 10-fold cross validation method, the training
dataset was  randomly divided into 10 disjoint subsets. Each subset
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Table  3
Summary of training dataset for CART classiﬁcation.
Class labels Description No. of records
0% unexpected
mass loss
Batches with no unexpected
mass loss at all
284
0–5% unexpected Batches with unexpected mass 75
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Fig. 5. The optimal CART decision tree based on a Monte Carlo simulation dataset.
Numerical values are the threshold levels of the split points for the correspond-
ing split conditions. Rectangle nodes are branch nodes which represent the process
parameters leading to split. Circle nodes are leaves representing subsets with dif-
ferent class labels for 0% unexpected mass loss, 0–5% unexpected mass loss or ≥5%mass loss loss less than 2 kg
≥5% unexpected
mass loss
Batches with unexpected mass
loss equal to or more than 2 kg
41
ad roughly equal size and roughly the same class proportions as in
he training set. Using nine of the subsets, all possible combinations
f trees were developed and these were then tested on the 10th sub-
et. This result provides a cross-validation error rate, which gives
n equitable evaluation of the predictive precision of tree mod-
ls of different sizes. Resubstitution error describes how well the
ecision tree ﬁts the training dataset while cross-validation error
escribes the prediction ability of the decision tree. A larger tree
as a smaller resubstitution error but can cause over-ﬁtting. The
ptimal tree should have the minimum cross-validation error and
olerance to resubstitution error.
In order to identify the key process ﬂuctuations driving whether
nexpected mass loss occurred or not, two CART trees have been
uilt separately. In Fig. 4(a), 0–5% and ≥5% unexpected mass loss
lasses have been merged into a >0% unexpected mass loss class
ersus the 0% unexpected mass loss class. The two-class tree
odel in Fig. 4(a) reveals that the CEX eluate volume and AEX
ig. 4. The optimal CART decision trees based on different class deﬁnitions. (a) CART
ree for 0% or >0% unexpected mass loss classes, (b) CART tree for <5% or ≥5% unex-
ected mass loss classes. Numerical values are the threshold levels of the split points
or the corresponding split conditions. Rectangle nodes are branch nodes (e.g. eluate
olume, titre) which represent the process parameters leading to split. Circle nodes
re leaves representing subsets with different class labels for unexpected mass loss
evels (e.g. <5% unexpected mass loss). The number in brackets in each leaf repre-
ents the percentage of observations in the leaf as an indicator of the conﬁdence
evel in the predictions.unexpected mass loss. The number in each leaf represents the percentage of obser-
vations in the leaf as an indicator of the conﬁdence level in the predictions.
eluate volume are the key process ﬂuctuations driving the level of
unexpected product mass loss occurring. Furthermore, from top to
bottom along the branch to each leaf node of the tree, the “if-then”
rules can be generated to describe and predict whether there is
unexpected mass loss or not caused by critical combinations of
key process ﬂuctuations. For example, the left branch of the tree
indicates that if CEX eluate volume <2.8 CV and AEX eluate volume
<4 CV, then there is no unexpected mass loss in the process with
prediction accuracy as high as 95%.
In Fig. 4(b), the 0% and 0–5% unexpected mass loss classes
have been merged to form <5% unexpected mass loss class versus
the ≥5% unexpected mass loss class. The two-class tree model in
Fig. 4(b) reveals that the key process ﬂuctuations leading to the
different unexpected mass loss outcomes in the base case process
are CEX eluate volume and product titre. As in Fig. 4(a), the “if-
then” rules can be generated to describe and predict what critical
combinations of key process ﬂuctuations result in <5% or ≥5% unex-
pected mass loss. The right branch of the tree indicates that if the
CEX eluate volume ≥3.1 CV and titre ≥3.88 g/L, then there is ≥5%
unexpected mass loss in the process with prediction accuracy as
high as 89%.
In order to explore the root causes for three categories of mass
levels (0% unexpected mass loss, 0–5% unexpected mass loss and
≥5% unexpected mass loss), rather than two, a three-class CART
tree has been built as shown in Fig. 5. This three-class tree model
reveals that the key process ﬂuctuations leading to different unex-
pected product mass loss levels in the base case process are product
titre, CEX eluate volume and AEX eluate volume. This reinforces the
partial correlation coefﬁcients analysis results in Fig. 3.
Comparing Figs. 4 and 5, the three-class tree in Fig. 5 is the com-
bination of the two-class trees in Fig. 4(a) and (b) but with the
subdivision of the >0% unexpected mass loss class of Fig. 4(a) and
<5% unexpected mass loss class of Fig. 4(b) so that it could reveal
more speciﬁc combinations of process ﬂuctuations leading to 0–5%
unexpected mass loss. However, the three-class tree in Fig. 5 has
lower prediction reliability than two-class trees due to the subdi-
vision of 0–5% unexpected mass loss and 5% unexpected mass loss
since they are both minority classes in the training dataset. Never-
theless, even with the lower prediction reliability the three-class
tree of Fig. 5 gives interesting insights. Similar classiﬁcation results
and prediction reliability have been reinforced by using a hyper-box
approach (Xu and Papageorgiou, 2009).
In order to clearly display the relationship between unexpected
mass loss distribution and the key process parameters identiﬁed
by the decision tree predictive model, windows of operation of
CEX eluate volume vs. AEX eluate volume under different titre
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Fig. 6. Windows of operation indicating critical combinations of AEX chromatog-
raphy eluate volume and CEX eluate volumes that drive mass loss levels for (a)
t
u
m
ﬂ
d
•
•
•itre < 3.88 g/L and (b) titre ≥ 3.88 g/L. The black area represents batches with ≥5%
nexpected mass loss, dark grey areas represent batches with 0–5% unexpected
ass loss and light grey areas represent batches with 0% unexpected mass loss.
uctuation ranges were generated in Fig. 6. Key observations
educed from analysis of Fig. 6 are highlighted below:
When the AEX eluate volume is below 4.0 CV and CEX eluate
volume is below 2.8 CV, there is no unexpected mass loss at
all irrespective of the titre ﬂuctuations as illustrated in Fig. 6(a)
and (b). When the CEX eluate volume lies within 2.8–3.1 CV and
AEX eluate volume lies within 4.0–4.5 CV, 0–5% unexpected mass
loss occurs irrespective of the titre ﬂuctuations. These observa-
tions reveal the required eluate volume ranges for the installed
5000 L pool tanks to handle the titre ﬂuctuations whilst accepting
unexpected mass losses up to the 5% threshold.
When the CEX eluate volume is in the range of 3.1–3.75 CV, the
level of unexpected mass loss depends on whether the titre is
higher than 3.88 g/L or not. The analysis shows that the unex-
pected mass loss will exceed the threshold of 5% if the titre is
above 3.88 g/L. Higher titres can increase the probability of need-
ing more cycles to process a batch. This combined with the higher
number of column volumes collected as eluate leads to higher
pool volumes than can exceed the installed capacity.
Eluate volumes in AEX and CEX are the dominant factors at 0–5%
and 0% unexpected mass loss levels while titre and CEX eluate
volume are the dominant factors at ≥5% unexpected mass loss
level as indicated in the decision tree in Fig. 5. Furthermore, unex-
pected mass loss levels in the CEX step are more sensitive to
titre ﬂuctuations than in the AEX step. This observation can be
attributed to the lower dynamic binding capacity of the CEX resinnology 179 (2014) 17–25 23
(15 g/L versus 50 g/L), which results in higher cycle numbers that
amplify the effect of eluate volume ﬂuctuations on tank volume
limitations.
The results highlight the greater level of information that can
be derived through uncertainty analysis combined with the deci-
sion tree analysis compared to the traditional approach in industry
based on calculations using expected or worst-case values. The
uncertainty analysis provides more information as it simulates all
possible combinations of variability and indicates the likelihood of
different levels of unexpected mass loss. In contrast, facility ﬁt using
worst case values alone can lead to equipment being oversized and
batch costs rising to cope with events that have a low likelihood of
occurrence. The decision tree analysis adds to the insights by pro-
viding a series of rules for the critical combinations of parameter
values that lead to different mass loss levels.
4.4. Debottlenecking solutions comparison
Having identiﬁed the critical combinations of parameter values
leading to loss, it was possible to propose debottlenecking solutions
and evaluate their impact on three key performance metrics: mass
output, direct COG/g and time. In this work, the direct COG/g cap-
tures the key direct costs incurred when running a batch such as
the consumable costs (e.g. resins), buffer costs (e.g. elution buffer),
and operator costs. Changes in indirect costs such as the poten-
tial increase in operating overhead costs due to purchasing new
equipment were not accounted for in this analysis. The effect of dif-
ferent solutions on time was also translated into changes in plant
throughput and hence impacted the cost of goods per gram. Three
debottlenecking solutions were explored relating to purchasing
larger tanks to accommodate the eluate volume ﬂuctuations, nar-
rowing the eluate volume ﬂuctuation through buffer optimization
and purchasing higher capacity resins that require fewer cycles.
These are discussed in more detail below.
4.4.1. Debottlenecking solution 1—New vessel
Introducing 40% larger volume pool tanks to AEX, CEX and VI
steps (using 7000 L to replace 5000 L) to handle the predicted peak
product volumes results in no product being discarded in any of
the process ﬂuctuation scenarios. In Fig. 7(a), the mass throughput
result of this solution (dotted line) is much improved compared
to the base case facilities (solid line) with most batches meeting
the expected throughput of 21 kg/batch. The improvement on the
direct COG/g can also be seen in Fig. 7(b) (dotted line). However,
this solution needs an extra 6 h processing time per batch than the
base case facility as shown in Fig. 8 since larger output volumes
from AEX and CEX need to be processed.
Introducing larger vessels is a natural and simple way to solve
the bottlenecks caused by tank size mismatching. However, this
change can be an expensive solution not only because of the cost
of larger vessels but also due to downtime and physical limitations
such as space which may  incur retroﬁtting costs during installation.
A further shortcoming of this solution is unsustainability. When
titre becomes higher, larger vessels are needed again.
4.4.2. Debottlenecking solution 2—New buffer
Based on the decision tree result in Fig. 5, reducing the eluate
volumes of the CEX and AEX steps to 2.8 CV and 4.0 CV accordingly
can avoid product mass loss using the base case facility. Tighten-
ing the ﬂuctuations in eluate volumes of AEX and CEX from 50% to
10% would require design of experiment (DoE) studies to be con-
ducted that focus on optimising the buffer components and their
pH and conductivity. In Fig. 7(a), the mass output result of solution 2
(dashed line) is as good as solution 1 (dotted line) with most batches
meeting the expected throughput of 21 kg/batch. The improvement
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Fig. 7. Probability distributions for the (a) mass output and (b) direct COG/g from the base case facility and three different debottlenecking solutions: new vessel (dotted
line),  new buffer (dashed line) and new resin (dot–dashed line). RMU  = relative monetary units.
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n the direct COG/g can also be seen in Fig. 7(b) (dashed line). The
verage batch processing time is the same as base case facility as
hown in Fig. 8.
Generally speaking, solution 2 can give the same performance
mprovement as solution 1 but does not require larger vessels or
pace considerations. The cost of solution 2 is buffer optimisation
tudies which can potentially be cheaper than solution 1, although
his depends on the development effort required.
.4.3. Debottlenecking solution 3—New resin
Using higher capacity resin for AEX and CEX steps can reduce the
umber of cycles so that the total output volumes of puriﬁcation
teps can be reduced. Newer resins with a dynamic binding capacity
f 100 g/L and 40 g/L for AEX and CEX steps, respectively were used
n the analysis. In Fig. 7(a), the mass output result of solution 3
dot–dashed line) is better than the base case but not as good as
olutions 1 and 2. The direct COG/g of solution 3 is also higher than
olution 2 and 3 in Fig. 7(b) due to the higher price of the newer
esins.
Compared to other solutions, the most attractive advantage of
olution 3 is the saving in the average batch processing time of two
ays per batch as shown in Fig. 8. However, if there is already slack
n the schedule to meet annual demands, then the saving offered
y solution 3 becomes less important.
The above discussion shows how the facility ﬁt analysis can
nform a facility manager about the bottlenecks in the process
nd help to suggest solutions. Three solutions were proposed for
he mAb  facility; however, the ﬁnal choice would depend on con-
iderations of likely future constraints such as further anticipated
ncreases in titre or increases in production.acility and different debottlenecking solutions.
5. Conclusion
This work introduced the CART decision tree method to explore
the impact of process ﬂuctuations on product mass loss and to
extract rules on the critical combinations of parameter values
that lead to mass loss. A series of if-then rules generated by the
decision tree method can be used to better understand the ﬂuc-
tuations in key process parameters leading to mass loss, to ﬁnd
out where the critical process constraints are and to predict the
product loss. The case study in this work demonstrated that the
decision tree results can provide ideas for debottlenecking solu-
tions with different impacts on space requirements, extra expense
and processing time. The analysis suggested that narrowing the
eluate volume ﬂuctuations expected through buffer optimisation
would be an attractive sustainable solution, where possible. Com-
bining this with the new higher capacity resins investigated in the
paper would mean that the titre limit of the base case facility could
increase from the original 2 g/L to 5 g/L without processes experi-
encing unexpected mass loss.
The work reported in this paper has examined the impact of
new processes with process ﬂuctuations on the mass output of an
existing facility. The same methods have potential for other key per-
formance metrics in commercial manufacturing processes such as
facility run rate and batch processing time. In addition, such meth-
ods can be applied to examine facility bottlenecks that occur not
only in the process steps but also in ancillary operations such as util-
ity generation (e.g. water-for-injection, WFI) or buffer preparation.Acknowledgments
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